FdaApplication

NDA 020655

Back to search

Identifiers

Properties

PropertyValue
applicant_nameABBVIE INC
application_typeNDA
approval_date1996-12-20

Products (4)

ProductActive ingredientStrengthDosage form
ALORAESTRADIOL0.075MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
ALORAESTRADIOL0.05MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
ALORAESTRADIOL0.1MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL
ALORAESTRADIOL0.025MG/24HRFILM, EXTENDED RELEASE;TRANSDERMAL

4 products